Latest filing published 28 Feb 2022 for Jagsonpal Pharmaceuticals Limited, €635k.
Filing timeline
BuySaleARESKO PREGRESSIVE PVT. LTD. As partner J & P Investments Partnership: trading record in brief
ARESKO PREGRESSIVE PVT. LTD. As partner J & P Investments Partnership appears in our data through filings on Jagsonpal Pharmaceuticals Limited shares, published by SEBI (PIT + SAST). Between 24 February 2022 and 25 February 2022, the trades on record add up to 2 filings.
Every open-market trade on record is a sale: 2 sales worth €1.2M.
On 28 February 2022 came the latest disclosure, an open-market sale for €635k in Jagsonpal Pharmaceuticals Limited. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to ARESKO PREGRESSIVE PVT. LTD. As partner J & P Investments Partnership
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 225,737 shares@ ₹238.118353.4% of flowEquity SharesSEBI:7b38152b5dfaefc01970fed47f7ac223baa3dfd5
- 199,763 shares@ ₹234.145446.6% of flowEquity SharesSEBI:90cb01504951037d7bcaabb3c77c0f986eeeaaf1
2 of 2 declarations